Age-Related Reduction of NO Availability and Oxidative Stress in Humans

By S. Taddei, A. Virdis, L. Ghiadoni, G. Salvetti, G. Bernini, A. Magagna, A. Salvetti. HYPERTENSION, 2001

665 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Endothelial Dysfunction: Cardiovascular Risk Factors, Therapy, and Outcome (2005, neutral): “These alterations are similar but anticipated in hypertensive patients compared with normotensive individuals (Taddei et al 2001).”
Aging and arterial stiffness. (2010, background): “48 Pharmacological treatments include (1) antihypertensive treatment such as diuretics, α-blockers, angiotensinconverting enzyme (ACE) inhibitors, angiotensin-receptor blockers (ARB), and calcium-channel antagonists;49 (2) treatment of congestive heart failure, such as with ACE inhibitors, nitrates,”
Endothelial dysfunction and vascular disease – a 30th anniversary update (2017, background): “…et al. 1997, Taddei et al. 1998, Benndorf et al. 2007, Naya et al. 2007, Kang et al. 2011a, Khan et al. 2012, Liu et al. 2012b, Zepeda et al. 2012) and probably reflects the premature ageing of the vasculature exposed chronically to the increased arterial blood pressure (Taddei et al. 1997b, 2001).”